This inventor holds 1 USPTO granted patent. Top assignee: Lipotec, S.a.. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Marc Canas Poblet: Innovator in Somatostatin Analog Synthesis
Introduction
Marc Canas Poblet is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of biochemistry, particularly in the synthesis of somatostatin analogs. His innovative approach has led to advancements in medical applications, showcasing his expertise and dedication to research.
Latest Patents
Marc Canas Poblet holds a patent for a procedure for obtaining the somatostatin analog, octreotide. This procedure involves solid phase synthesis on polymer supports and utilizes protector groups of the Fmoc/tBu type. The patent details the construction of a seven amino acid linear peptide, which includes various steps such as treatment of the resulting peptidyl-resin with acid and the incorporation of the threoninol residue. This innovative method ultimately leads to the production of octreotide, a compound with significant therapeutic potential.
Career Highlights
Marc is currently associated with Lipotec, S.A., where he continues to apply his expertise in peptide synthesis. His work has been instrumental in advancing the understanding and production of somatostatin analogs, which are crucial in various medical treatments. With a patent portfolio that includes 1 patent, Marc has established himself as a key figure in his field.
Collaborations
Throughout his career, Marc has collaborated with talented professionals such as Berta Ponsati Obiols and Gemma Jodas Farres. These collaborations have fostered a productive environment for innovation and research, contributing to the success of their projects.
Conclusion
Marc Canas Poblet is a distinguished inventor whose work in the synthesis of somatostatin analogs has made a significant impact in the field of biochemistry. His innovative procedures and collaborations highlight his commitment to advancing medical science.